Gilead Sciences said Wednesday that remdesivir, which has been authorized for emergency use since the spring, brought in $873 million in revenues so far this year.
from Health https://ift.tt/31QSZsg
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment